B-Cell Lymphoma Treatment
1 clinical trials · Condition
◉ Watch B-Cell Lymphoma Treatment
| Record | Firm | Date |
|---|---|---|
| Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy Failure (NCT06918912) | Istituto Clinico Humanitas | 2023-06-16 |
Track B-Cell Lymphoma Treatment automatically
Every clearance here is in the API, with alerts when new ones post.